Pharmacy Times provides pharmacy practice news and expert insights, focusing on issues relevant to pharmacy professionals.

Pharmacy Times

Media Production

MJH Life Sciences®

Pharmacy Times | 82,889 followers on LinkedIn. Everything pharmacy, every day. | Pharmacy Times is a clinically-based, monthly journal providing practical information pharmacists can use in their everyday practice. Each issue contains articles and features covering medication errors, drug interactions, patient education, pharmacy technology, disease state management, patient counseling, product news, pharmacy law, and specialty pharmacy. Pharmacy Times Continuing Education (PTCE) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Principal at Genesis Pharma Consultants

Dan Steiber

Executive Vice-President and Chief Impact Officer

Nimesh Jhaveri

The Digital Apothecary (Professor, Clinician, Public Speaker, and Advisor)

Timothy Aungst, PharmD.

Proofreader at MJH Associates, Inc

Maggie Shaw

Your pharmacy news, streamlined. We're bringing curated content straight to your feed with our new newsletter. 📰 What matters most to you? #PharmacyTimesPoll #Pharmacy #LinkedinNewsletter

Pharmacists can help patients to understand individual joint health needs and encourage them to follow healthy lifestyle habits as part of their proactive joint health regimen. #pharmacist Learn more: https://lnkd.in/eAk-ZVpF

The FDA proposed the removal of oral phenylephrine (Sudafed PE; Johnson & Johnson) as an active ingredient in OTC drug products for the temporary relief of nasal congestion. The proposal is based on extensive review by the agency, which found that oral phenylephrine is not effective for this use. Learn more: https://bit.ly/3CkMItO

Pharmacists, who play a crucial role at the intersection of prescribing and dispensing, are well-positioned to influence these racial disparities in opioid prescriptions. Learn more: https://bit.ly/4fBljlQ

Researchers announced positive findings from the phase 2b/3 MK-1654-004 clinical trial that assessed clesrovimab (MK-1654; Merck), an investigational monoclonal prophylactic monoclonal antibody designed to protect infants from respiratory syncytial virus (RSV) infection in their first RSV season. Learn more: https://bit.ly/3NUIFXR

The FDA approved minocycline hydrochloride extended-release capsules (DFD-29, Emrosi; Journey Medical) for the treatment of adults with inflammatory lesions caused by rosacea. Learn more: https://bit.ly/3YznMpY

In the Institute for Safe Medication Practices (ISMP) National Vaccine Errors Reporting Program (VERP), investigators reported that the majority of reported errors (82.3%) reached the patient, with the most reported errors including administering the wrong vaccine (25.2%) and administering an expired vaccine (19.8%). Learn more: https://bit.ly/3UAtvKM

At the FLASCO Fall Session, American Society of Clinical Oncology (ASCO) VP of Care Delivery Stephen Grubbs, MD, FASCO, highlighted the increasing impact of pharmacists within ASCO, from developing safety standards to leading quality improvement and certification initiatives. With pharmacists, such as Michael Reff of NCODA and Alexandre Chan, PharmD, MPH, FCCP, FISOPP, BCPS, BCOP, APh of UCI School of Pharmacy & Pharmaceutical Sciences , significantly contributing to ASCO/NCODA and ASCO/ONS standards, ASCO aims to expand opportunities and address barriers—potentially such as CE credits for pharmacists at its annual meeting—to further support pharmacists crucial role in oncology care. #OncologyPharmacy #PharmacistImpact #ASCO #QualityCare https://lnkd.in/eCyZ39jW

Although the number of active shortages decreased to 277 in the second quarter of 2024 from an all-time high of 323 in the second quarter of 2023, 50% of the active shortages in the United States persisted for 2 or more years. Learn more: https://bit.ly/3AcPT6l

No tricks, just treatments! We hope you find the perfect prescription for a safe and spooky Halloween. 👻🎃 #HappyHalloween #PharmacyCare #PharmacyTimes

OTC Guide

Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

DNSSEC

Content Delivery Network

LetsEncrypt

DoubleClick.Net

New Jersey Companies With Less Than $10M in Revenue (Top 10K)

New Jersey Companies With Fewer Than 100 Employees (Top 10K)

Northeastern US Publishing Companies

Greater New York Area Companies With Less Than $10M in Revenue (Top 10K)

Pharmacy Times is a clinically-based, monthly journal providing practical information pharmacists can use in their everyday practice. Each issue contains articles and features covering medication errors, drug interactions, patient education, pharmacy technology, disease state management, patient counseling, product news, pharmacy law, and specialty pharmacy. The Pharmacy Times Office of Continuing Professional Education (CPE) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Pharmacy Times is owned by Intellisphere, LLC, a leading provider of health care publishing, research, information, and education. Operating within both traditional and digital media channels, Intellisphere serves the needs of health care professionals through an extensive suite of magazines, journals, e-mail databases, Web sites, events, and personal meetings. With publications such as Pharmacy Times, Specialty Pharmacy Times, Oncology & Biotech News, OncologyLive, Contemporary Oncology, Urologists in Cancer Care, Oncology Nursing News, The American Journal of Managed Care, The American Journal of Pharmacy Benefits, Targeted Therapy News, The International Journal of Targeted Therapies in Cancer, and HCPlive.com as part of the publishing group, Intellisphere reaches more than half a million health care professional across nearly all segments of care.

news impact assignment basic	general
public peers	general	Nov 12, 2024 2:56 AM	1e3e3732
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 12, 2024 2:56 AM	57d2ec98
crunchbase trigger	general	Nov 12, 2024 2:56 AM	558c8fb6
crunchbase profile	general	Nov 12, 2024 10:58 AM	9be58221
li profile	general	Nov 12, 2024 2:56 AM	a34b5c3a
translate crunchbase fundingrounds	general	Nov 12, 2024 11:36 AM	5c0cc9f3
peers	general	Nov 12, 2024 2:56 AM	4d0b7e05
news basic	general	Nov 12, 2024 2:56 AM	7748c668
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

PHAR

COM:PHARMACYTIMES

Pharmacy Times